Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg and gradually increasing every 4 weeks to a maintenance dose ranging from 5 mg to 15 mg (with intermediate steps of 7.5 mg and 12.5 mg), depending on individual response and tolerability
In animal studies, use of the medication was associated with lower birth weights
The majority of caregivers reported that patients experienced hyperphagia (68%) and half of patients experienced obesity (52%)
Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law
Maintenance of weight loss with continued treatment, demonstrating sustained outcomes when use is maintained within protocol (in maintenance trials)
Namely, the coat will lack luster, it may be very flaky, and be seemingly thin and dry
US$ 25.70
US$ 23.15
US$ 24.69
US$ 21.60
US$ 21.26
US$ 27.49
